Simplex Trading
VIR icon

Simplex Trading’s Vir Biotechnology VIR Stock Holding History

Simplex Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,010
Closed -$59.6K – 10194
2025
Q3 		$57K Buy
10,010
+7,464
+293% +$38.2K ﹤0.01% 6328
2025
Q2 		$12K Buy
2,546
+1,757
+223% +$9.42K ﹤0.01% 7205
2025
Q1 		$5K Sell
789
-115,838
-99% -$1.03M ﹤0.01% 7610
2024
Q4 		$856K Buy
116,627
+112,354
+2,629% +$886K ﹤0.01% 3004
2024
Q3 		$32K Sell
4,273
-13,680
-76% -$119K ﹤0.01% 6309
2024
Q2 		$159K Buy
17,953
+13,221
+279% +$127K ﹤0.01% 4877
2024
Q1 		$47K Buy
4,732
+2,938
+164% +$29.9K ﹤0.01% 6316
2023
Q4 		$18K Buy
+1,794
New +$16.4K ﹤0.01% 7030
2022
Q4 		– Sell
-4,082
Closed -$100K – 10535
2022
Q3 		$78K Buy
+4,082
New +$104K ﹤0.01% 5864
2022
Q2 		– Sell
-12,364
Closed -$289K – 11188
2022
Q1 		$318K Sell
12,364
-9,334
-43% -$277K ﹤0.01% 4466
2021
Q4 		$908K Buy
21,698
+17,311
+395% +$678K ﹤0.01% 2995
2021
Q3 		$190K Sell
4,387
-13
-0.3% -$563 ﹤0.01% 5682
2021
Q2 		$208K Buy
+4,400
New +$200K ﹤0.01% 5619
2020
Q4 		– Sell
-1,141
Closed -$37.1K – 9147
2020
Q3 		$39K Buy
1,141
+1,081
+1,802% +$46.5K ﹤0.01% 5853
2020
Q2 		$2K Sell
60
-69
-53% -$2.32K ﹤0.01% 7286
2020
Q1 		$4K Buy
+129
New +$3.47K ﹤0.01% 6988

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Simplex Trading's VIR Position: Q4 2025 in Review

Simplex Trading sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 10,010 shares — an estimated $59.6K sold.

Simplex Trading first reported a position in VIR in Q1 2020 and held it in 16 quarters. The position peaked at $908K in Q4 2021. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • Simplex Trading reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 10,010 Vir Biotechnology shares in Q4 2025, an estimated $59.6K.
  • Simplex Trading first reported a position in Vir Biotechnology in Q1 2020 and held it in 16 quarters.
  • Simplex Trading's Vir Biotechnology position peaked at $908K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.